Other equities analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of German American Bancorp. from a buy rating to a hold rating in a research note on Tuesday, April 30th. ValuEngine raised shares of Zogenix from a buy rating to a strong-buy rating in a research note on Thursday, June 27th.
IOSP opened at $92.16 on Friday. The stock has a market capitalization of $2.26 billion, a PE ratio of 19.08 and a beta of 1.31. The company’s fifty day moving average is $87.31. Innospec has a fifty-two week low of $53.07 and a fifty-two week high of $94.79. The company has a quick ratio of 1.45, a current ratio of 2.28 and a debt-to-equity ratio of 0.25.
In other Innospec news, VP Catherine Hessner sold 2,000 shares of Innospec stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $83.64, for a total value of $167,280.00. Following the completion of the transaction, the vice president now directly owns 20,923 shares of the company’s stock, valued at approximately $1,749,999.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 4,300 shares of company stock valued at $356,236 over the last three months. Corporate insiders own 1.62% of the company’s stock.
Large investors have recently modified their holdings of the business. Avestar Capital LLC bought a new stake in shares of Innospec in the 1st quarter worth about $66,000. Grandfield & Dodd LLC bought a new stake in shares of Innospec in the 1st quarter worth about $200,000. Campbell & CO Investment Adviser LLC bought a new stake in shares of Innospec in the 2nd quarter worth about $201,000. First Citizens Bank & Trust Co. bought a new stake in shares of Innospec in the 1st quarter worth about $202,000. Finally, O Shares Investment Advisers LLC bought a new stake in shares of Innospec in the 1st quarter worth about $220,000. 93.34% of the stock is owned by institutional investors and hedge funds.
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.
Further Reading: Dividend
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.